Skip to main content

Table 1 Orally administered glucocorticoid (prednisone/prednisolone) dosing in the RITAZAREM trial

From: Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial

  Induction schedule A
(1 mg/kg group)
Induction schedule B
(0.5 mg/kg group)
Week <60 kg ≥60 kg <60 kg ≥60 kg
0 50 mg/day 60 mg/day 25 mg/day 30 mg/day
2 35 mg/day 45 mg/day 20 mg/day 25 mg/day
4 25 mg/day 35 mg/day 17.5 mg/day 20 mg/day
6 20 mg/day 25 mg/day 15 mg/day 17.5 mg/day
8 15 mg/day 17.5 mg/day 12.5 mg/day 15 mg/day
10 12.5 mg/day 12.5 mg/day
12 10 mg/day 10 mg/day